Seyed Hamidreza Rastegar-Moghaddam

, Mahmoud Hosseini

, Fatemeh Amin, Elham Ehsani, Sara Asadi, Farimah Beheshti, Farzaneh Shakeri
*
Abstract
Introduction: This study aimed to evaluate the therapeutic potential of aminoguanidine (AG),an inducible nitric oxide synthase (iNOS) inhibitor, in attenuating renal and cardiac fibrosis and oxidative stress in juvenile rats with experimentally induced hypothyroidism.
Methods: Hypothyroidism was induced by administering 0.05% propylthiouracil (PTU) in drinking water for six weeks. Thirty-five rats were assigned to five groups: control, hypothyroid only, and three hypothyroid groups treated with AG (10, 20, or 30 mg/kg, i.p.). Serum thyroxine(T4), blood urea nitrogen (BUN), and creatinine levels were measured to assess thyroid and renalfunction. Oxidative stress markers including malondialdehyde (MDA), thiol content, superoxide dismutase (SOD), and catalase (CAT) were evaluated in serum, and aorta, heart, and kidneytissues. Cardiac and renal fibrosis was examined using Masson’s trichrome staining.
Results: Rats receiving PTU alone developed overt hypothyroxinemia, as evidenced by a marked reduction in serum T4, together with elevated levels of BUN and creatinine. Cardiac and renal tissues from PTU-treated animals exhibited fibrosis, accompanied by increased malondialde hydeconcentrations and concomitant decreases in antioxidant defenses, including thiol groups, superoxide dismutase, and catalase activity. Co-administration of AG effectively reversedthese alterations, restoring serum T4 and tissue antioxidant parameters while lowering BUN, creatinine, and malondialdehyde levels. The highest dose of AG also decreased cardiorenal fibrosis compared to the PTU group.
Conclusion: The present findings demonstrate that pharmacological inhibition of iNOS attenuates oxidative stress and cardiorenal fibrosis in experimental hypothyroidism. Although aminoguanidine exhibits recognized limitations for clinical application due to safety concerns,these results support the involvement of the iNOS pathway in hypothyroidism-associated tissue injury and highlight iNOS modulation as a potential mechanistic target for future investigations.